Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun;165(2):139-145.
doi: 10.5507/bp.2020.035. Epub 2020 Sep 10.

Introducing a new prognostic instrument for long-term mortality prediction in COPD patients: the CADOT index

Kristian Brat  1   2 , Michal Svoboda  3   2 , Karel Hejduk  2 , Marek Plutinsky  1   2 , Jaromir Zatloukal  4 , Eva Volakova  4 , Patrice Popelkova  5 , Barbora Novotna  6 , Dita Engova  7 , Frits M E Franssen  8   9 , Lowie E G W Vanfleteren  10 , Martijn A Spruit  8   11   9 , Vladimir Koblizek  12
Affiliations
Free article

Introducing a new prognostic instrument for long-term mortality prediction in COPD patients: the CADOT index

Kristian Brat et al. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2021 Jun.
Free article

Abstract

Objectives: The BODE (BMI, Obstruction - FEV1, Dyspnoea - mMRC, Exercise - 6-MWT) and the ADO (Age, Dyspnoea - mMRC, Obstruction - FEV1) indices are widely used prognosis assessment tools for long-term mortality prediction in COPD patients but subject to limitations for use in daily clinical practice. The aim of this research was to construct a prognostic instrument that prevents these limitations and which would serve as a complementary prognostic tool for clinical use in these patients.

Methods and participants: The data of 699 COPD subjects were extracted from the Czech Multicentre Research Database (CMRD) of COPD patients (the derivation cohort) and analysed to identify factors associated with the long-term risk of mortality. These were entered into the ROC analysis and reclassification analysis. Those with the strongest discriminative power were used to construct the new index (CADOT). The new index was validated on 187 patients of the CIROCO+ cohort (Netherlands; the validation cohort).

Results: The CADOT was constructed by adding two newly identified prognosis-determining factors, chronic heart failure (CHF) and TLCO, to the ADO index. In a head-to-head comparison, the CADOT index showed highest c-statistic values compared to the BODE and ADO indices (0.701 vs 0.677 vs 0.644, respectively). The prognostic power was more definitive when applied to the Dutch validation (CIROCO+) cohort (0.842 vs 0.799 vs 0.825, respectively).

Conclusions: The CADOT index has comparable prognostic power to the BODE and ADO indices. The CADOT is complementary/an alternative to the BODE (if 6-MWT is not feasible) and ADO (with less dependence on the age factor) indices.

Trial registration: ClinicalTrials.gov (NCT01923051).

Keywords: COPD; mortality; prognostic index; pulmonary function.

PubMed Disclaimer

Associated data